Indian MedTech Acquisitions: BPL Makes a Bold Medec Move
Indian MedTech acquisitions: BPL takes a majority stake in Medec for patents, pipeline and 30+ country reach. What is reported and undisclosed.
Indian MedTech Acquisitions: BPL Makes a Bold Medec Move
Indian MedTech acquisitions: BPL takes a majority stake in Medec for patents, pipeline and 30+ country reach. What is reported and undisclosed.
ICMR Funding for Medical Devices: Major Rs 15 Cr Boost
ICMR funding for medical devices: up to Rs 15 crore per centre over five years for seven centres. What it means for domestic industry.
Maharashtra FDA Hospital Inspection: Vendor Risk Exposed
Maharashtra FDA hospital inspection: the Fortis Mulund kitchen suspension and what it means for outsourced hospital services.
Bundibugyo Virus Outbreak: No Vaccine Raises Alarm
Bundibugyo virus outbreak: no approved vaccine or treatment as the DR Congo epidemic reaches an eighth province. What trials are under way.
Government Cancer Drug Pricing Policy: Bold Margin Cap
Government cancer drug pricing policy widens as NPPA caps trade margins on 137 medicines. What it means for makers, hospitals and supply.
Pharmaceutical Compounding Safety: South Africa’s Warning
Pharmaceutical compounding safety is the focus as South Africa reviews rules for GLP-1 weight-loss injections. What regulators found and what is proposed.
Vanda Pharmaceuticals Social Anxiety Drug: Hard Setback
Vanda Pharmaceuticals social anxiety drug VQW-765 is on hold after a Phase 3 miss. What it means for the pipeline and the alpha-7 approach.
BD ChloraPrep Applicator Recall: Dangerous Kit Fallout
BD ChloraPrep applicator recall: how one contaminated component forced whole-kit destruction in an AVID Medical IV start kit lot. Supply-chain lessons.
CDC Measles Outbreak Response: Critical Epi-Aid Boost
CDC measles outbreak response: what Epi-Aid brings to Pennsylvania as cases hit 1,222, and why counting the true burden of an outbreak is hard.
